Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth

Por el Filali, Mariam, Homminga, Irene, Maat, Willem, van der Velden, Pieter A., Jager, Martine J.
Publicado em 2008

Associations between asthma, overweight and physical activity in children: a cross-sectional study

Por Willeboordse, Maartje, van de Kant, Kim D. G., van der Velden, Charlotte A., van Schayck, Constant P., Dompeling, Edward
Publicado no BMC Public Health (2016)

A Locus Linked to p16 Modifies Melanoma Risk in Dutch Familial Atypical Multiple Mole Melanoma (FAMMM) Syndrome Families

Por van der Velden, Pieter A., Sandkuijl, Lodewijk A., Bergman, Wilma, Hille, Elysée T.M., Frants, Rune R., Gruis, Nelleke A.
Publicado em 1999

Melanocortin-1 Receptor Variant R151C Modifies Melanoma Risk in Dutch Families with Melanoma

Por van der Velden, Pieter A., Sandkuijl, Lodewijk A., Bergman, Wilma, Pavel, Stan, van Mourik, Leny, Frants, Rune R., Gruis, Nelleke A.
Publicado em 2001

Bevacizumab and intraocular tumors: an intriguing paradox

Por el Filali, Mariam, Ly, Long V., Luyten, Gregorius P.M., Versluis, Mieke, Grossniklaus, Hans E., van der Velden, Pieter A., Jager, Martine J.
Publicado em 2012

PRAME as an independent biomarker for metastasis in uveal melanoma

Por Field, Matthew G., Decatur, Christina L., Kurtenbach, Stefan, Gezgin, Gülçin, van der Velden, Pieter A., Jager, Martine J., Kozak, Kaleigh N., Harbour, J. William
Publicado no Clin Cancer Res (2016)

Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy

Por Sluijter, Marjolein, van der Sluis, Tetje C., van der Velden, Pieter A., Versluis, Mieke, West, Brian L., van der Burg, Sjoerd H., van Hall, Thorbald
Publicado em 2014

EMT-associated factors promote invasive properties of uveal melanoma cells

Por Asnaghi, Laura, Gezgin, Gülçin, Tripathy, Arushi, Handa, James T., Merbs, Shannath L., van der Velden, Pieter A., Jager, Martine J., Harbour, J. William, Eberhart, Charles G.
Publicado no Mol Vis (2015)

Embryonic Zebrafish: Different Phenotypes after Injection of Human Uveal Melanoma Cells

Por van der Ent, Wietske, Burrello, Claudia, de Lange, Mark J., van der Velden, Pieter A., Jochemsen, Aart G., Jager, Martine J., Snaar-Jagalska, B. Ewa
Publicado no Ocul Oncol Pathol (2015)

Mrassf1a-Pap, a Novel Methylation-Based Assay for the Detection of Cell-Free Fetal DNA in Maternal Plasma

Por van den Oever, Jessica M. E., Balkassmi, Sahila, Segboer, Tim, Verweij, E. Joanne, van der Velden, Pieter A., Oepkes, Dick, Bakker, Egbert, Boon, Elles M. J.
Publicado em 2013

Episodic Src activation in uveal melanoma revealed by kinase activity profiling

Por Maat, W, Filali, M el, Mulder, A Dirks-, Luyten, G P M, Gruis, N A, Desjardins, L, Boender, P, Jager, M J, van der Velden, P A
Publicado em 2009

Feasibility of an eHealth application “OncoKompas” to improve personalized survivorship cancer care

Por Duman-Lubberding, S., van Uden-Kraan, C.F., Jansen, F., Witte, B.I., van der Velden, L.A., Lacko, M., Cuijpers, P., Leemans, C.R., Verdonck-de Leeuw, I.M.
Publicado no Support Care Cancer (2015)

Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy

Por Cao, Jinfeng, Heijkants, Renier C., Jochemsen, Aart G., Dogrusöz, Mehmet, de Lange, Mark J., van der Velden, Pieter A., van der Burg, Sjoerd H., Jager, Martine J., Verdijk, Robert M.
Publicado no Oncotarget (2016)

Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development

Por Zuidervaart, W, van der Velden, P A, Hurks, M H, van Nieuwpoort, F A, Out-Luiting, C J J, Singh, A D, Frants, R R, Jager, M J, Gruis, N A
Publicado em 2003

Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma

Por Versluis, Mieke, de Lange, Mark J., van Pelt, Sake I., Ruivenkamp, Claudia A. L., Kroes, Wilma G. M., Cao, Jinfeng, Jager, Martine J., Luyten, Gre P. M., van der Velden, Pieter A.
Publicado no PLoS One (2015)

Skewed Expression of the Genes Encoding Epigenetic Modifiers in High-Risk Uveal Melanoma

Por Herlihy, Naoimh, Dogrusöz, Mehmet, van Essen, T. Huibertus, Harbour, J. William, van der Velden, Pieter A., van Eggermond, Marja C. J. A., Haasnoot, Geert W., van den Elsen, Peter J., Jager, Martine J.
Publicado no Invest Ophthalmol Vis Sci (2015)

GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi

Por Vader, M J C, Madigan, M C, Versluis, M, Suleiman, H M, Gezgin, G, Gruis, N A, Out-Luiting, J J, Bergman, W, Verdijk, R M, Jager, M J, van der Velden, P A
Publicado no Br J Cancer (2017)

Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients

Por van Dijk, Elon H. C., Duits, Danique E. M., Versluis, Mieke, Luyten, Gregrorius P. M., Bergen, Arthur A. B., Kapiteijn, Ellen W., de Lange, Mark J., Boon, Camiel J. F., van der Velden, Pieter A.
Publicado no Medicine (Baltimore) (2016)

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment

Por Gezgin, Gülçin, Dogrusöz, Mehmet, van Essen, T. Huibertus, Kroes, Wilhelmina G. M., Luyten, Gregorius P. M., van der Velden, Pieter A., Walter, Vonn, Verdijk, Robert M., van Hall, Thorbald, van der Burg, Sjoerd H., Jager, Martine J.
Publicado no Cancer Immunol Immunother (2017)

Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism

Por de Lange, Mark J., Razzaq, Lubna, Versluis, Mieke, Verlinde, Sven, Dogrusöz, Mehmet, Böhringer, Stefan, Marinkovic, Marina, Luyten, Gregorius P. M., de Keizer, Rob J. W., de Gruijl, Frank R., Jager, Martine J., van der Velden, Pieter A.
Publicado no PLoS One (2015)